Reaching out beyond first-line treatments in advanced biliary tract cancers
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.Issue Date
2020
Metadata
Show full item recordCitation
Lamarca A, Valle JW. Reaching out beyond first-line treatments in advanced biliary tract cancers. Ann Oncol. 2020.Journal
Annals of OncologyDOI
10.1016/j.annonc.2020.06.002PubMed ID
32569724Additional Links
https://dx.doi.org/10.1016/j.annonc.2020.06.002Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.annonc.2020.06.002
Scopus Count
Collections
Related articles
- Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial.
- Authors: Demols A, Borbath I, Van den Eynde M, Houbiers G, Peeters M, Marechal R, Delaunoit T, Goemine JC, Laurent S, Holbrechts S, Paesmans M, Van Laethem JL
- Issue date: 2020 Sep
- Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme.
- Authors: Moehler M, Maderer A, Schimanski C, Kanzler S, Denzer U, Kolligs FT, Ebert MP, Distelrath A, Geissler M, Trojan J, Schütz M, Berie L, Sauvigny C, Lammert F, Lohse A, Dollinger MM, Lindig U, Duerr EM, Lubomierski N, Zimmermann S, Wachtlin D, Kaiser AK, Schadmand-Fischer S, Galle PR, Woerns M, Working Group of Internal Oncology
- Issue date: 2014 Dec
- Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
- Authors: Abdel-Rahman O, Elsayed Z, Elhalawani H
- Issue date: 2018 Apr 6
- Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a meta-analysis.
- Authors: Yang R, Wang B, Chen YJ, Li HB, Hu JB, Zou SQ
- Issue date: 2013 Sep
- Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study.
- Authors: Larsen FO, Markussen A, Diness LV, Nielsen D
- Issue date: 2018